<DOC>
	<DOCNO>NCT02543099</DOCNO>
	<brief_summary>The purpose study assess clinical efficacy safety policosanol elderly patient endothelial dysfunction</brief_summary>
	<brief_title>Efficacy Safety Study Policosanol</brief_title>
	<detailed_description>100 select elderly patient endothelial dysfunction randomize two group , Group1 : receive policosanol 20mg qd ; Group2 : receive placebo 20mg qd；endothelial function test peripheral arterial tonometry ( PAT ) 6 month ' treatment policosanol placebo respectively ; Endothelial dysfunction define reactive hyperemia index ( RHI ) &lt; 1.67 ; The aim study assess clinical efficacy safety policosanol elderly patient endothelial dysfunction .</detailed_description>
	<mesh_term>Policosanol</mesh_term>
	<criteria>1 . Age 60 year old； 2 . Patients endothelial dysfunction 3 . Provision inform consent prior study specific procedure . 1 . Acute myocardial infarction , severe trauma , major operation stroke within six month ; 2 . Tumor inflammatory disease 3 . Known allergy policosanol 4 . Life expectancy less 1 year 5. secondary dyslipidemia 6.taking experimental medicine within six month ;</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>policosanol</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>